Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar

GET THE APP

The Anti-cancer Properties Of Crocin And Epirubicin On Chemosensitive Cervical Cancer Cells | 91110
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2154

Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

The anti-cancer properties of crocin and epirubicin on chemosensitive cervical cancer cells

Annual Biotechnology Congress

Reyhane Hoshyar, Arash Ghorbani and Homa Mollaei

University of Medical Sciences, Iran

Posters & Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X-C3-095

Abstract
Cervical cancer is still one of the leading causes of death amongst women in the developing countries. Although there are many adopted strategies for declining its symptoms such as surgery, radiotherapy, chemotherapy and their combination following tumor resection, tumor recurrence is usually occurring due to cancer cell resistance to chemotherapy. Also, damaged normal cells are another drawback of these therapies. Hence, today many studies have been accomplished to investigate anticancer characteristics of natural agents such as medicinal plants. Among them, the tumorical properties of crocin on different kinds of cancerous cell lines are interested in many scholars. In this study, the sensitive human cervical cancer cell line (OV2008) was exposed to crocin and epirubicin to investigate the molecular mechanism of this combination. A 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenylte- trazolium bromide (MTT) assay revealed that proliferation of sensitive cells (OV2008) was declined by crocin and epirubicin combination at a time- and dose-dependent manner (0-24-48 h). Hoechst staining assay also proved these results and showed that antiproliferative effect of crocin and epirubicin might be due to the induction of apoptosis. Furthermore, up-regulating of Bax and down-regulating of Bcl2 expression lead to achieving the genetic mechanism of crocin- epirubicin apoptosis induction in this cell line. Escalating LDH releases announced that crocin combined with epirubicin had an apoptotic effect on this cancerous cell. Regarding these results, the combination of crocin and epirubicin can play proliferative and apoptotic roles against sensitive cervical cancer cells which may be used as an adjuvant agent for cervical cancer treatment to increase the efficiency of therapy.
Biography

Reyhane Hoshyar is an Associate Professor at Department of Clinical Biochemistry, School of Medicine, Director of Cellular and Molecular Research Center, Director of Health Technology Office, Birjand University of Medical Sciences, Birjand, Iran since 2013. Her field of interest is in Molecular Biology of diseases especially cancer.

E-mail: hooshyar@bums.ac.ir

Top